Rate and characteristics of infection after transrectal prostate biopsy: a retrospective observational study

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Tandoğdu Z. The dilemma of increasing antibiotic resistance in the prostate: Increasing prevalence of biopsy-related complications and increasing incidence of antibiotic resistance. Presented at: Joint meeting of the EAU Section of Infections in Urology (ESIU) and the EAU Section of Urological Imaging (ESUI) - Prepare for the future: Prevent, detect, strike back! 34th annual European Association of Urology Congress 2019; 2019 March 15–19; Barcelona, Spain.
   Google Scholar
• Johansen TEB, Zahl PH, Baco E, et al. Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry. World J Urol. 2020;38(1):17–26.
   PubMed Web of Science ®Google Scholar
• Liss MA, Ehdaie B, Loeb S, et al. An update of the American Urological Association white paper on the prevention and treatment of the more common complications related to prostate biopsy. J Urol. 2017;198(2):329–334.
   PubMed Web of Science ®Google Scholar
• Liss MA, Johnson JR, Porter SB, et al. Clinical and microbiological determinants of infection after transrectal prostate biopsy. Clin Infect Dis. 2015;60(7):979–987. 1
   PubMed Web of Science ®Google Scholar
• Loeb S, Vellekoop A, Ahmed HU, et al. Systematic review of complications of prostate biopsy. Eur Urol. 2013;64(6):876–892.
   PubMed Web of Science ®Google Scholar
• Nam RK, Saskin R, Lee Y, et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol. 2013;189(1 Suppl):S12–S17. discussion S17–S18.
   PubMed Web of Science ®Google Scholar
• Roberts MJ, Bennett HY, Harris PN, et al. Prostate biopsy-related infection: a systematic review of risk factors, prevention strategies, and management approaches. Urology. 2017;104:11–21.
   PubMed Web of Science ®Google Scholar
• Rawla P, El Helou ML, Vellipuram AR. Fluoroquinolones and the risk of aortic aneurysm or aortic dissection: a systematic review and meta-analysis. Cardiovasc Hematol Agents Med Chem. 2019;17(1):3–10.
   PubMedGoogle Scholar
• Mottet N, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79(2):243–262.
   PubMed Web of Science ®Google Scholar
• Raman JD, Lehman KK, Dewan K, et al. Povidone iodine rectal preparation at time of prostate needle biopsy is a simple and reproducible means to reduce risk of procedural infection. J Vis Exp. 2015;103:52670.
   Google Scholar
• Pilatz A, Veeratterapillay R, Koves B, et al. Update on strategies to reduce infectious complications after prostate biopsy. Eur Urol Focus. 2019;5(1):20–28.
   PubMedGoogle Scholar
• Fahmy A, Rhashad H, Mohi M, et al. Optimizing prophylactic antibiotic regimen in patients admitted for transrectal ultrasound-guided prostate biopsies: a prospective randomized study . Prostate Int. 2016;4(3):113–117.
   PubMed Web of Science ®Google Scholar
• Dai J, Leone A, Mermel L, et al. Rectal swab culture-directed antimicrobial prophylaxis for prostate biopsy and risk of postprocedure infection: a cohort study. Urology. 2015;85(1):8–14.
   PubMed Web of Science ®Google Scholar
• Carignan A, Roussy JF, Lapointe V, et al. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Eur Urol. 2012;62(3):453–459.
   PubMed Web of Science ®Google Scholar
• Lahdensuo K, Rannikko A, Anttila VJ, et al. Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005-2013: a population-based analysis. Prostate Cancer Prostatic Dis. 2016;19(4):417–422.
   PubMed Web of Science ®Google Scholar
• Teillant A, Gandra S, Barter D, et al. Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study. Lancet Infect Dis. 2015;15(12):1429–1437.
   PubMed Web of Science ®Google Scholar
• World Health Organization. ICD-10: International Statistical Classification of disease and related health problems: 10th revision. 2016. [cited 2020 Oct 29]. Available from: https://icd.who.int/browse10/2016/en.
   Google Scholar
• Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):762–774.
   PubMed Web of Science ®Google Scholar
• Sveriges Kommuner och Regioner. Vårdrelaterade infektioner. 2017.
   Google Scholar
• Nationellt vårdprogram. Prostatacancer. 2020. [cited 2020 Oct 21]. Available from: https://www.cancercentrum.se/globalassets/cancerdiagnoser/prostatacancer/vardprogram/nationellt-vardprogram-prostatacancer.pdf.
   Google Scholar
• Bennett HY, Roberts MJ, Doi SAR, et al. The global burden of major infectious complications following prostate biopsy. Epidemiol Infect. 2016;144(8):1784–1791.
   PubMed Web of Science ®Google Scholar
• Lundstrom KJ, Drevin L, Carlsson S, et al. Nationwide population based study of infections after transrectal ultrasound guided prostate biopsy. J Urol. 2014;192(4):1116–1122.
   PubMed Web of Science ®Google Scholar
• Danielsen L, Faizi G, Snitgaard S, et al. Infections after transrectal ultrasonic guided prostate biopsies – a retrospective study. Scand J Urol. 2019;53(2–3):97–101.
   PubMed Web of Science ®Google Scholar
• Antibiotikaresistensrapport för Escherichia coli: Årsrapport för Region Skåne (SE120) från blododling 2017. Folkhälsomyndigheten 2017.
   Google Scholar
• Gross MD, Alshak MN, Shoag JE, et al. Healthcare costs of post-prostate biopsy sepsis. Urology. 2019;133:11–15.
   PubMed Web of Science ®Google Scholar
• Roth H, Millar JL, Cheng AC, et al. The state of TRUS biopsy sepsis: readmissions to Victorian hospitals with TRUS biopsy-related infection over 5 years. BJU Int. 2015;116(Suppl 3):49–53.
   PubMedGoogle Scholar
• Anastasiadis E, van der Meulen J, Emberton M. Hospital admissions after transrectal ultrasound-guided biopsy of the prostate in men diagnosed with prostate cancer: a database analysis in England. Int J Urol. 2015;22(2):181–186.
   PubMed Web of Science ®Google Scholar
• Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2020. Geneva: World Health Organization; 2020.
   Google Scholar